investorscraft@gmail.com

Intrinsic ValueYongyue Science&Technology Co.,Ltd (603879.SS)

Previous Close$6.25
Intrinsic Value
Upside potential
Previous Close
$6.25

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Yongyue Science & Technology Co., Ltd. operates as a specialized chemical producer focused on synthetic resins within China's basic materials sector. The company's core revenue model centers on the research, development, production, and sale of unsaturated polyester resins and polyurethane products, serving various industrial applications. Operating in the highly competitive specialty chemicals industry, Yongyue leverages its technical expertise to cater to domestic market demands for high-performance polymer materials. The company maintains a regional market position primarily concentrated in Quanzhou and surrounding areas, competing against larger chemical conglomerates while focusing on specific resin formulations. Its business strategy emphasizes technological development and production efficiency to maintain relevance in a sector characterized by intense competition and cyclical demand patterns. The company's market positioning reflects a niche player in China's broader chemical manufacturing landscape, targeting specific industrial customers requiring specialized synthetic resin solutions.

Revenue Profitability And Efficiency

The company reported revenue of CNY 370.4 million for the period but experienced significant financial challenges with a net loss of CNY 165.5 million. Operating cash flow was negative at CNY 35.8 million, indicating substantial operational headwinds and potential liquidity constraints. Capital expenditures remained minimal at CNY 0.1 million, suggesting limited investment in capacity expansion or technological upgrades during this challenging period.

Earnings Power And Capital Efficiency

Yongyue's earnings power was severely impacted with diluted EPS of -CNY 0.46, reflecting substantial operational difficulties. The negative operating cash flow combined with minimal capital expenditures indicates poor capital efficiency and constrained investment capacity. The company's ability to generate returns on invested capital appears significantly challenged given the current financial performance and market conditions.

Balance Sheet And Financial Health

The balance sheet shows CNY 33.9 million in cash and equivalents against total debt of CNY 10.6 million, indicating a moderate liquidity position despite operational challenges. The debt level appears manageable relative to cash reserves, though negative cash flow generation raises concerns about medium-term financial sustainability. The company's financial health requires careful monitoring given the current operational performance.

Growth Trends And Dividend Policy

Current financial performance indicates contraction rather than growth, with significant losses impacting shareholder value. The company maintained a zero dividend policy, consistent with its loss-making position and need to preserve capital. Future growth prospects depend on operational turnaround and improved market conditions in the specialty chemicals sector.

Valuation And Market Expectations

With a market capitalization of CNY 2.24 billion, the market valuation appears disconnected from current financial performance, potentially reflecting recovery expectations or strategic value. The beta of 0.635 suggests lower volatility than the broader market, possibly indicating perceived stability despite operational challenges. Valuation metrics must be interpreted cautiously given the company's current loss position.

Strategic Advantages And Outlook

The company's specialized focus on synthetic resins provides niche market positioning, though current operational challenges overshadow any strategic advantages. The outlook remains challenging given negative profitability and cash flow, requiring significant operational improvements. Success depends on market recovery, cost management, and potentially strategic repositioning within the competitive chemicals landscape.

Sources

Company financial reportsShanghai Stock Exchange disclosuresMarket data providers

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount